Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 10/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 4/20 | 0.32 |
| ▸ | RARG | P13631 | 1/20 | 0.30 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8304309 | 1.00 | PPARG (0.52) | PPARGHTTFFAR1RARGRXRA | |
| SCHEMBL8309649 | 0.91 | PPARG (0.48) | PPARGHTTFFAR1RARGRXRA | |
| SCHEMBL8309646 | 0.91 | PPARG (0.48) | PPARGHTTFFAR1RARGRXRA | |
| SCHEMBL8310076 | 0.87 | PPARG (0.54) | PPARGHTTFFAR1RARGRXRA | |
| SCHEMBL8305170 | 0.87 | PPARG (0.69) | PPARGHTTFFAR1RARGRXRA | |
| SCHEMBL8310074 | 0.87 | PPARG (0.54) | PPARGHTTFFAR1RARGRXRA | |
| SCHEMBL8305173 | 0.87 | PPARG (0.69) | PPARGHTTFFAR1RARGRXRA | |
| SCHEMBL8304974 | 0.86 | PPARG (0.54) | PPARGHTTFFAR1RARGRXRA | |
| SCHEMBL8304976 | 0.86 | PPARG (0.54) | PPARGHTTFFAR1RARGRXRA | |
| SCHEMBL8305873 | 0.85 | PPARG (0.52) | PPARGHTTFFAR1RARGRXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5972959-A | Oxime derivatives, their preparation and their therapeutic use | SANKYO COMPANY, LIMITED (JP) | 1999-10-26 | — | — | US | disclosed |
| EP-0708098-B1 | Oxime derivatives, their preparation and their therapeutic use | SANKYO CO (JP) | 1999-03-03 | — | — | EP | disclosed |
| EP-0708098-A1 | Oxime derivatives, their preparation and their therapeutic use | SANKYO COMPANY LIMITED (JP) | 1996-04-24 | — | — | EP | disclosed |